Primus Capital Leads $40M Series B in PurpleLab

Primus Capital Invests in Bloomfire

August 16, 2021

Cloud & SaaS

Primus Capital announced a growth equity investment in Austin-based Bloomfire, a knowledge engagement SaaS platform. As part of the transaction Primus principals will join Bloomfire's board and will partner with management to accelerate product innovation, pursue M&A opportunities, and drive growth across enterprise and mid-market customers.

Primus Capital Leads Recapitalization and Growth Investment in Trilliant Health

November 18, 2019

Data & Analytics

Primus Capital led a major growth investment and recapitalization in Trilliant Health, a healthcare analytics company based near Nashville, Tennessee. Existing investors — Providence Ventures, Martin Ventures, Noro-Moseley Partners, and Nashville Capital Network — also participated to support Trilliant’s product development, data science hiring, and national expansion of its analytics platform for health systems.

Primus Capital Invests in Prendio and BioProcure

October 18, 2023

Cloud & SaaS

Primus Capital has made a growth equity investment in Prendio and sister company BioProcure to support organic growth, expansion into additional life-sciences markets, and continued product and service innovation. The investment will back Prendio's cloud-based eProcurement SaaS and BioProcure's procure-to-pay support services for biotech customers; Aeris Partners served as exclusive financial advisor to the sellers and law firms Latham & Watkins and Goodwin Proctor served as legal advisors.

Primus Capital Makes Growth Investment in Cayuse; Quad Partners Reinvests

August 27, 2020

Cloud & SaaS

Primus Capital led a major growth investment in Cayuse, the Portland-based market leader in cloud-native research administration software. Quad Partners and its affiliates reinvested alongside Primus to support Cayuse’s product innovation, platform expansion and continued strategic acquisitions; Macquarie Capital served as Cayuse’s financial advisor.

Primus Capital Makes Strategic Growth Investment in CORL Technologies

January 5, 2022

Healthcare Services

Primus Capital has made a strategic growth investment in CORL Technologies, a healthcare-focused vendor risk management provider, to accelerate CORL’s product, data, and services expansion. The capital will support investments in CORL’s vendor risk technology, data exchange platform, and managed services to scale its solutions for healthcare providers, payors, and vendors.

1315 Capital Invests in Primrose Bio

June 17, 2024

Biotechnology

1315 Capital, a Philadelphia-based healthcare-focused growth equity firm, made a significant equity investment in Primrose Bio to support development and commercial expansion of Primrose’s nucleic acid and protein manufacturing technologies. The funding will accelerate commercialization of the company’s Prima RNApols, Pfenex expression system, and PeliCRM carrier protein for therapeutics and vaccines.